Name | 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione,hydrochloride |
---|---|
Synonyms |
Tipiracil HCl
5-amino-1-[(5-chloro-2,6-dihydroxypyrimidin-4-yl)methyl]-3,4-dihydro-2H-pyrrolium chloride 2,4(1H,3H)-Pyrimidinedione, 5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-, hydrochloride (1:1) TAS-1-462 Tipiracil hydrochloride 2H-pyrrolium, 5-amino-1-[(5-chloro-2,6-dihydroxy-4-pyrimidinyl)methyl]-3,4-dihydro-, chloride (1:1) 5-Chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-2,4(1H,3H)-pyrimidinedione hydrochloride (1:1) Tipiracil hydrochloride (JAN) |
Description | Tipiracil (hydrochloride) is a thymidine phosphorylase inhibitor (TPI), used for cancer research. |
---|---|
Related Catalog | |
In Vitro | Tipiracil has antiangiogenic effect, and inhibits proliferation of endothelial cells[1]. Tipiracil is a potent inhibitor of thymidine phosphorylase, which is the enzyme that degrades FTD[2]. |
References |
[1]. Peters GJ, et al. TAS-102: more than an antimetabolite. Lancet Oncol. 2012 Dec;13(12):e518-9. |
Molecular Formula | C9H12Cl2N4O2 |
---|---|
Molecular Weight | 279.123 |
Exact Mass | 278.033722 |
PSA | 93.33000 |
LogP | 1.95390 |
Storage condition | 2-8°C |
RIDADR | NONH for all modes of transport |
---|